NPCE Q1 2024 Earnings — NeuroPace, Inc. Revenue & Financial Results | Market Cap Arena

NPCENeuroPace, Inc.

$482M

Q1 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$18M+25.2% YoY

Gross Profit

$13M73.6% margin

Operating Income

-$8M-41.6% margin

Net Income

-$9M-49.2% margin

EPS (Diluted)

$-0.32

QoQ Revenue Growth

+0.6%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$99M

Total Liabilities

$85M

Stockholders' Equity

$14M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18M	$14M	+25.2%
Gross Profit	$13M	$10M	+28.6%
Operating Income	-$8M	-$8M	+9.3%
Net Income	-$9M	-$10M	+14.0%